COLYTE 10.65 MG
POTASSIUM CHLORIDE : 10.65 MG SODIUM SULFATE : 81.2 MG POLYETHYLENE GLYCOL 3350 : 857.69 MG SODIUM CHLORIDE : 20.87 MG SODIUM BICARBONATE : 24.02 MG · DIN 00677442 · PENDOPHARM DIVISION OF PHARMASCIENCE INC
Health Canada status: MARKETED
What is COLYTE?
COLYTE 10.65 MG contains POTASSIUM CHLORIDE : 10.65 MG SODIUM SULFATE : 81.2 MG POLYETHYLENE GLYCOL 3350 : 857.69 MG SODIUM CHLORIDE : 20.87 MG SODIUM BICARBONATE : 24.02 MG. It is listed in the Health Canada Drug Product Database under DIN 00677442, held by PENDOPHARM DIVISION OF PHARMASCIENCE INC, supplied as POWDER FOR SOLUTION for ORAL ; NASOGASTRIC administration. Health Canada currently lists it as marketed, status dated 01-Apr-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is COLYTE used for?
Colyte® (PEG 3350 and Electrolytes) is indicated for bowel cleansing prior to colonoscopy or barium enema x-ray examination or surgical procedures requiring a clean colon. It is also used for the treatment of constipation.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00677442 |
|---|---|
| Brand name | COLYTE |
| Generic / active ingredient | POTASSIUM CHLORIDE : 10.65 MG SODIUM SULFATE : 81.2 MG POLYETHYLENE GLYCOL 3350 : 857.69 MG SODIUM CHLORIDE : 20.87 MG SODIUM BICARBONATE : 24.02 MG |
| Manufacturer | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Strength | 10.65 MG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | ORAL ; NASOGASTRIC |
| Schedule | Ethical |
| ATC code | A06AD65 MACROGOL, COMBINATIONS |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 01-Apr-2013 |
| Original market date | 1986-12-31 00:00:00 |
How is it stored and handled?
Store Colyte® powder at room temperature, between 15°C and 30°C. Once reconstituted, the solution should be used within 48 hours after mixing if stored at room temperature. If kept refrigerated (between 2°C and 8°C), use within 30 days. Discard unused portion.
How is it supplied?
Each 278 g bottle of Colyte® powder, to be dissolved in 4 L of water
What can be used instead?
Other Canadian products sharing ATC code A06AD65 MACROGOL, COMBINATIONS. 3 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMPLYTE | 22.96 G / 280 G | POWDER | JAMP PHARMA CORPORATION | MARKETED | DIN 02378329 |
| MOVIPREP | 2.691 G | POWDER FOR SOLUTION | ARALEZ PHARMACEUTICALS CANADA INC | MARKETED | DIN 02359499 |
| JAMP-ELECTROPEG | 2.97 G | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | APPROVED | DIN 02406780 |
| JAMP-ELECTROPEG WITH FLAVOUR PACKET | 2.97 G | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | APPROVED | DIN 02406799 |
| JAMPLYTE | 0.76 G | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | APPROVED | DIN 02368234 |
| KLEAN-PREP | 1.68 G | POWDER FOR SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02147793 |
| PLENVU | 9 G | KIT ; POWDER FOR SOLUTION | BAUSCH HEALTH, CANADA INC. | CANCELLED PRE MARKET | DIN 02550938 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.